SCHEMBL29320158

SCHEMBL29320158

CCc1cc(C2CNCCN2)ccc1C(=O)OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSL P07711 1/20 0.39
CTSB P07858 1/20 0.39
CTSS P25774 1/20 0.39
CTSK P43235 1/20 0.39
KMT2A Q03164 2/20 0.38
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 2/20 0.35
HPGD P15428 2/20 0.35
MAPT P10636 1/20 0.35
SLC6A2 P23975 3/20 0.34
SLC6A4 P31645 3/20 0.34
HTT P42858 1/20 0.33
MEN1 O00255 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
PDK2 Q15119 1/20 0.33
PDK4 Q16654 1/20 0.33
CA9 Q16790 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31056427 0.85 CTSL (0.38) CTSLCTSBCTSSCTSKKMT2A
SCHEMBL29320338 0.85 CA12 (0.48) CTSLCTSBCTSSCTSKKMT2A
SCHEMBL29325641 0.85 CTSL (0.38) CTSLCTSBCTSSCTSKKMT2A
SCHEMBL29321284 0.84 ALDH1A1 (0.48) CTSLCTSBCTSSCTSKKMT2A
SCHEMBL31056902 0.84 CTSL (0.40) CTSLCTSBCTSSCTSKKMT2A
SCHEMBL29325561 0.84 CTSL (0.40) CTSLCTSBCTSSCTSKKMT2A
SCHEMBL25076845 0.77 KDM4E (0.47) KMT2AALDH1A1KDM4EHPGDMAPT
SCHEMBL30988614 0.77 KDM4E (0.47) KMT2AALDH1A1KDM4EHPGDMAPT
SCHEMBL12488979 0.76 ALDH1A1 (0.41) KMT2AALDH1A1KDM4EHPGDMAPT
SCHEMBL29320165 0.74 XIAP (0.34) KMT2AALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024148274-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2024-07-11 WO disclosed
WO-2024148274-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2024-07-11 WO disclosed